Cell Culture Development Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cell Culture Development's estimated annual revenue is currently $9.3M per year.(i)
  • Cell Culture Development's estimated revenue per employee is $155,000

Employee Data

  • Cell Culture Development has 60 Employees.(i)
  • Cell Culture Development grew their employee count by 7% last year.

Cell Culture Development's People

NameTitleEmail/Phone
1
Director Quality ControlReveal Email/Phone
2
Director, R&DReveal Email/Phone
3
Procurement Specialist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Cell Culture Development?

Avioq is an in vitro diagnostic medical device manufacturer and a contract development, contract manufacturing organization. Based in Research Triangle Park, North Carolina Avioq has a FDA licensed manufacturing facility and large, modern R&D laboratories. Our products include an FDA licensed HTLV-I/II assay for screening serum and plasma from blood donor and cadaveric samples, which also has CE marking and Health Canada approval. The Avioq HIV-1 assay is the only product with FDA approved claims for testing serum, plasma, dried blood spots, and oral fluid specimens. The FDA approved HIV Profile™ assay is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of HIV-1 (Group M & Group O) and HIV-2 in human serum or plasma. It is intended as an additional, more specific test to confirm the presence of antibodies in specimens repeatedly reactive in diagnostic procedures. Why work with Avioq for your next CDMO project? Instead of using consultants who talk about the regulatory process we actually live it. We develop and manufacture our own FDA and CE Mark products to the highest standards. The manufacturing facility is FDA (BLA) licensed and ISO 13485:2106 certified. The facility has been inspected numerous times by FDA and ISO, as well as by external partners. Need a quick answer? We can help you with: ● Exploratory research ● Proof of concept projects ● Feasibility studies ● Research lots If you entrust your project to Avioq, we will focus on getting your product through our mature Quality System, approvable by Regulatory Authorities, manufactured and to market as quickly as possible. Our team will guide you past the regulatory delays and pitfalls. Our R&D, quality and manufacturing teams have successfully designed and developed numerous medical diagnostic products during the past 25 years.

keywords:N/A

N/A

Total Funding

60

Number of Employees

$9.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cell Culture Development News

2022-04-20 - FiberCell Systems Offers a Better Way to Grow Cells for ...

The hollow fiber systems also overcome a tricky challenge seen in cell culture and protein production – TGFbeta, which is a known growth inhibitor produced by...

2022-04-20 - Toppan and Myoridge to Collaborate on Products, Services ...

The collaboration will aim to accelerate the development of Toppan's 3D cell culture technology and generate new related products and...

2022-04-17 - 908 Devices and CPI Team on Cell Culture Media ...

Data generated from the REBEL can be used to develop predictive models for feed control.” About the REBEL analyzer. REBEL is a first-of-its-kind...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M627%N/A
#2
$75M6710%N/A
#3
$35M676%N/A
#4
$6.2M68-15%N/A
#5
$1.7M723%N/A